INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,372 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CM
Cairns MichaelChief Credit Officer
LOBLive Oak Bancshares, Inc.
Tax withholding
F$14K
420 sh
Dec 9, 2025Dec 10, 2025
Page 1658 of 1835
← PrevNext →
traded Dec 9, 2025
+1d
SEC Form 4

Evidence

9
SG
Schjotz GitteSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
9 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HS
Hong SooDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
TK
Talluri Rajendra KDirector, President and CEO
ENVXEnovix Corp
Tax withholding
F$37K
4,292 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HF
Hecker FriedrichDirector
ULSUL Solutions Inc.
Grant or award
A—
4 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
25.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
GF
Goins Melanie FGeneral Counsel and CPO
DIBS1stdibs.com, Inc.
Option exercise
M—
10.0K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
CA
Chakravarthy ArthiChief Legal Officer
ENVXEnovix Corp
Tax withholding
F$8,107
934 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
CC
Culloty Maeve CEVP, Pres & CEO Financial Serv
HPEHewlett Packard Enterprise Co
Option exercise
M—
3,325 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
88.3K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
DN
Doherty John N.EVP, CFO
BFLYButterfly Network, Inc.
Grant or award
A—
863.2K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HS
Hong SooDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.5K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
85.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
CS
Chapin Linda SEVP & CHRO
ULSUL Solutions Inc.
Grant or award
A—
4 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HH
Hancock Lynn HSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
5 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
MB
MacDonald Neil BEVP, GM, Server
HPEHewlett Packard Enterprise Co
Grant or award
A—
146.7K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Grant or award
A—
85.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
MA
Marathe AjayChief Operating Officer
ENVXEnovix Corp
Tax withholding
F$13K
1,490 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SM
Sondel MichaelCAO (principal acct. officer)
ADIANALOG DEVICES INC
Grant or award
A—
203 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
2,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
HH
Hancock Lynn HSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
3 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
UA
Uggetti AlbertoEVP & CCO
ULSUL Solutions Inc.
Grant or award
A—
5 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
DL
Dillow Stacy LEVP, Chief People Officer
HPEHewlett Packard Enterprise Co
Grant or award
A—
77.5K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
DS
Dreyer ScottEVP & Chief Commercial Officer
COLLCOLLEGIUM PHARMACEUTICAL, INC
Option exercise · 10b5-1 plan
M$280K
17.6K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
FN
Franklin Denson N. IIISVP, Gen. Counsel & Secretary
VMCVulcan Materials CO
Option exercise
M—
3,200 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
GF
Goins Melanie FGeneral Counsel and CPO
DIBS1stdibs.com, Inc.
Option exercise
M—
5,331 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HW
Hooper Charles WDirector
ULSUL Solutions Inc.
Grant or award
A—
4 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
54.9K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
1,250 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
DS
D'Angelo ScottEVP, CLO & Corporate Secy
ULSUL Solutions Inc.
Grant or award
A—
14 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
DA
Dadakis AlexSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
26 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
7,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
85.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
44.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
3,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
40.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
GA
Genovesi John ASee Remarks
ULSUL Solutions Inc.
Grant or award
A—
6 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
GA
Genovesi John ASee Remarks
ULSUL Solutions Inc.
Grant or award
A—
6 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence